Baird Medical Investment Holdings Limited (BDMD) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 14.58M | 7.96M | 23.9M | 13.14M | 11.55M |
| Revenue Growth % | -39.01% | -39.41% | - | 13.77% | - |
| Cost of Goods Sold | 2.23M | 1.42M | 2.74M | 1.65M | 2.04M |
| COGS % of Revenue | 15.29% | 17.89% | 11.46% | 12.53% | 17.69% |
| Gross Profit | 12.35M | 6.54M | 21.16M | 11.49M | 9.5M |
| Gross Margin % | 84.71% | 82.11% | 88.55% | 87.47% | 82.31% |
| Gross Profit Growth % | -41.65% | -43.13% | - | 20.92% | - |
| Operating Expenses | 27.53M | 16.99M | 10.94M | 6.4M | 6.51M |
| OpEx % of Revenue | 188.84% | 213.4% | 45.76% | 48.73% | 56.38% |
| Selling, General & Admin | 14.58M | 9.81M | 6.79M | 4.37M | 4.22M |
| SG&A % of Revenue | 100% | 123.19% | 28.41% | 33.3% | 36.58% |
| Research & Development | 12.95M | 7.18M | 4.15M | 2.03M | 2.29M |
| R&D % of Revenue | 88.84% | 90.21% | 17.35% | 15.43% | 19.8% |
| Other Operating Expenses | 0 | 0 | 0 | -4 | 1 |
| Operating Income | -15.18M | -10.45M | 10.23M | 5.09M | 2.99M |
| Operating Margin % | -104.14% | -131.29% | 42.79% | 38.74% | 25.93% |
| Operating Income Growth % | -248.45% | -305.35% | - | 70.01% | - |
| EBITDA | -14.55M | -9.66M | 10.77M | 5.68M | 3.41M |
| EBITDA Margin % | -99.84% | -121.37% | 45.07% | 43.25% | 29.5% |
| EBITDA Growth % | -235.11% | -270.02% | - | 66.83% | - |
| D&A (Non-Cash Add-back) | 626.17K | 789.93K | 546.39K | 592.74K | 412.42K |
| EBIT | -15.18M | -10.44M | 10.23M | 5.09M | 2.99M |
| Net Interest Income | -379.46K | -357.45K | -337.7K | -238.66K | -82.39K |
| Interest Income | 0 | 762 | 0 | 0 | 0 |
| Interest Expense | 379.46K | 358.21K | 337.7K | 238.66K | 82.39K |
| Other Income/Expense | -394.58K | -349.59K | -994.99K | -232.76K | -56.44K |
| Pretax Income | -15.57M | -10.8M | 9.23M | 4.86M | 2.94M |
| Pretax Margin % | -106.84% | -135.69% | 38.62% | 36.97% | 25.44% |
| Income Tax | 607.02K | 559.13K | 1.01M | 481.28K | 581.92K |
| Effective Tax Rate % | -3.9% | -5.18% | 10.92% | 9.91% | 19.81% |
| Net Income | -15.98M | -11.29M | 8.12M | 4.33M | 2.33M |
| Net Margin % | -109.65% | -141.89% | 33.99% | 32.96% | 20.18% |
| Net Income Growth % | -296.77% | -360.81% | - | 85.82% | - |
| Net Income (Continuing) | -16.18M | -11.36M | 8.22M | 4.38M | 2.36M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -144.09K | 36.11K | 101.34K | 1.47K | 0 |
| EPS (Diluted) | -0.55 | -0.43 | 0.38 | -0.32 | 0.08 |
| EPS Growth % | -244.74% | -35.18% | - | -501.64% | - |
| EPS (Basic) | -0.55 | -0.43 | 0.38 | -0.32 | 0.08 |
| Diluted Shares Outstanding | 28.87M | 26.4M | 21.84M | 7.47M | 6.57M |
| Basic Shares Outstanding | 28.87M | 26.4M | 21.7M | 7.47M | 6.57M |
| Dividend Payout Ratio | - | - | - | - | - |